Deficiency of adenosine deaminase 2; special focus on central nervous system imaging. 2019

Elif Bulut, and Abdulsamet Erden, and Omer Karadag, and Kader Karli Oguz, and Seza Ozen
Department of Radiology, Hacettepe University Faculty of Medicine, Ankara, Turkey. Electronic address: drelifbulut@yahoo.com.

OBJECTIVE To increase the knowledge of central nervous system (CNS) imaging features in deficiency of adenosine deaminase 2 (DADA2) by examining magnetic resonance imaging (MRI) studies of a relatively large number of patients. METHODS We retrospectively examined neuroimages of 12 patients (7 male, 5 female) diagnosed with DADA2. The mean age of the patients at the time of initial brain MRI was 16.7±10.2 years. Seven patients (58.3%) fulfilled the classification criteria of polyarteritis nodosa. Brain MRI studies were assessed with respect to findings of ischemia, intracranial hemorrhages, focal parenchymal signal abnormalities, cerebral/cerebellar volume loss, and abnormal contrast enhancement. Angiographic studies of 7 patients were evaluated for the signs of vasculitis. RESULTS The most frequent finding was acute and/or chronic lacunar ischemic lesions in the brainstem and/or deep gray matter (n=9, 75%). Six patients (50%) revealed MRI findings compatible with recurrent ischemic attacks. Small nodular contrast enhancement (n=2, 16.6%), acute putaminal hemorrhage (n=1, 8.3%) and findings compatible with posterior reversible encephalopathy syndrome (n=1, 8.3%) were also detected. Slight-to-moderate diffuse cerebral and/or cerebellar volume loss (n=7, 58.3%), decreased T1 signal of the bone marrow (n=6, 50%) and optic atrophy (n=1, 8.3%) were the other findings on brain MRI. The only abnormal angiographic finding was reduced caliber of the right distal posterior cerebral artery in MRA of a patient (14.6%). CONCLUSIONS DADA2 should be included in the differential diagnosis of young patients presenting with ischemic and/or hemorrhagic lesions located in the brainstem and deep gray matter, especially if they have a family history or additional systemic abnormalities.

UI MeSH Term Description Entries
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001927 Brain Diseases Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM. Intracranial Central Nervous System Disorders,Brain Disorders,CNS Disorders, Intracranial,Central Nervous System Disorders, Intracranial,Central Nervous System Intracranial Disorders,Encephalon Diseases,Encephalopathy,Intracranial CNS Disorders,Brain Disease,Brain Disorder,CNS Disorder, Intracranial,Encephalon Disease,Encephalopathies,Intracranial CNS Disorder
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000243 Adenosine Deaminase An enzyme that catalyzes the hydrolysis of ADENOSINE to INOSINE with the elimination of AMMONIA. Adenosine Aminohydrolase,Aminohydrolase, Adenosine,Deaminase, Adenosine
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

Elif Bulut, and Abdulsamet Erden, and Omer Karadag, and Kader Karli Oguz, and Seza Ozen
October 1992, Antimicrobial agents and chemotherapy,
Elif Bulut, and Abdulsamet Erden, and Omer Karadag, and Kader Karli Oguz, and Seza Ozen
April 2016, Journal of clinical immunology,
Elif Bulut, and Abdulsamet Erden, and Omer Karadag, and Kader Karli Oguz, and Seza Ozen
October 2023, The Journal of infectious diseases,
Elif Bulut, and Abdulsamet Erden, and Omer Karadag, and Kader Karli Oguz, and Seza Ozen
March 2002, Cancer cell,
Elif Bulut, and Abdulsamet Erden, and Omer Karadag, and Kader Karli Oguz, and Seza Ozen
March 2023, Best practice & research. Clinical rheumatology,
Elif Bulut, and Abdulsamet Erden, and Omer Karadag, and Kader Karli Oguz, and Seza Ozen
March 2022, Histology and histopathology,
Elif Bulut, and Abdulsamet Erden, and Omer Karadag, and Kader Karli Oguz, and Seza Ozen
January 1998, Ryoikibetsu shokogun shirizu,
Elif Bulut, and Abdulsamet Erden, and Omer Karadag, and Kader Karli Oguz, and Seza Ozen
June 1987, Hospital practice (Office ed.),
Elif Bulut, and Abdulsamet Erden, and Omer Karadag, and Kader Karli Oguz, and Seza Ozen
January 2000, Ryoikibetsu shokogun shirizu,
Elif Bulut, and Abdulsamet Erden, and Omer Karadag, and Kader Karli Oguz, and Seza Ozen
January 1990, Immunodeficiency reviews,
Copied contents to your clipboard!